Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,549 | 627,667 | 51,087 | 55,984 | 13,237 |
| Marketable Securities | 776,264 | 483,592 | 353,208 | 346,629 | 244,152 |
| Receivables | 106 | 1,230 | 52 | 5,000 | 39 |
| TOTAL | $897,537 | $1,119,911 | $409,438 | $413,825 | $263,605 |
| Non-Current Assets | |||||
| PPE Net | 418 | 274 | 296 | 185 | 207 |
| Investments And Advances | 303,633 | 113,868 | 110,135 | 152,874 | 51,705 |
| Other Non-Current Assets | 11,683 | 12,831 | 11,053 | 10,561 | 10,559 |
| TOTAL | $315,734 | $126,973 | $121,484 | $163,620 | $62,471 |
| Total Assets | $1,213,271 | $1,246,884 | $530,922 | $577,445 | $326,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,390 | 5,274 | 9,725 | 6,705 | 5,404 |
| Accrued Expenses | 26,101 | 31,125 | 19,452 | 15,979 | 13,999 |
| TOTAL | $34,389 | $38,283 | $30,732 | $23,855 | $20,093 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,524 | 1,485 | 1,188 | 954 | 690 |
| Other Non-Current Liabilities | 913 | 965 | 1,019 | 1,068 | 1,119 |
| TOTAL | $6,857 | $7,287 | $6,789 | $7,136 | $2,904 |
| Total Liabilities | $41,246 | $45,570 | $37,521 | $30,991 | $22,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,934 | 54,666 | 44,471 | 42,876 | 32,188 |
| Common Shares | 55 | 54 | 43 | 43 | 32 |
| Retained earnings | -427,778 | -377,563 | -336,729 | -272,297 | -235,532 |
| Other shareholders' equity | -2,128 | -575 | 489 | 163 | 98 |
| TOTAL | $1,172,025 | $1,201,314 | $493,401 | $546,454 | $303,079 |
| Total Liabilities And Equity | $1,213,271 | $1,246,884 | $530,922 | $577,445 | $326,076 |